1-20 of 25 results for subject:Scientists
Librarians' tools
- Search time
- 0.211 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:Scientists
- We searched for
- subject_t:Scientists OR subject_ses:92918
Type
House
Session
More
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask Her Majesty’s Government what assessment they have made of the impact of the difference in salaries and fees between different professions on the number of professional engineering and science students choosing to work for government departments and agencies; and whether they intend to revise their policy in the...
To ask Her Majesty’s Government what assessment they have made of the impact of the difference in salaries and fees between different professions on the number of professional engineering and science students choosing to work for government departments and agencies; and whether they intend to revise their policy in the...
The government do not currently collect this information and so has not made an assessment of this kind.
To ask Her Majesty’s Government what data they collect regarding salaries and fees paid by government departments and agencies to professional engineers and scientists; and what assessment they have made of the comparison between these salaries and fees and those paid by government departments and agencies to financial and legal...
To ask Her Majesty’s Government what data they collect regarding salaries and fees paid by government departments and agencies to professional engineers and scientists; and what assessment they have made of the comparison between these salaries and fees and those paid by government departments and agencies to financial and legal...
Data on government scientist and engineer salaries are currently held by departmental HR teams. The data on salaries have not been collated centrally, and no such assessment has been made.
In October 2016, the GSE profession published its five year plan. This includes an action plan on Reward and Recognition that will include comparison between departmental practices which will be taken forward by a cross-government working group. They will be working closely with the Cabinet Office Civil Service Employment & Pay (CSEP) team, who will assist with the data collection involved and any benchmarking against industry and academia.
It is vital that we encourage talented women into scientific careers. Those working in science, technology, engineering and maths careers on average earn a pay premium of 19%. Ensuring that women work in STEM careers will also help to tackle the gender pay gap. Role models are absolutely crucial for young women, and some 40% of STEM ambassadors are women.
I would like to take this opportunity to put on record my thanks to Tim Peake, who did an amazing job of working with schools while he was on his space trip earlier this year. I have met many, many schoolchildren who have had their interest in STEM stimulated from the work he did while on his space trip.
It is vital that we encourage talented women into scientific careers. Those working in science, technology, engineering and maths careers on average earn a pay premium of 19%. Ensuring that women work in STEM careers will also help to tackle the gender pay gap. Role models are absolutely crucial for young women, and some 40% of STEM ambassadors are women.
I would like to take this opportunity to put on record my thanks to Tim Peake, who did an amazing job of working with schools while he was on his space trip earlier this year. I have met many, many schoolchildren who have had their interest in STEM stimulated from the work he did while on his space trip.
What steps she is taking to encourage more women to take up scientific professions.
In a free market, the shortage of science teachers to inspire young women would be addressed by a rising wage. It is worth a try.
In a free market, the shortage of science teachers to inspire young women would be addressed by a rising wage. It is worth a try.
We are trying to make sure that some of the very best graduates in STEM subjects go into teaching. Our bursary schemes help to encourage that. Some fantastic teachers are now coming into the profession, which will help us to further build the STEM pipeline.
We are trying to make sure that some of the very best graduates in STEM subjects go into teaching. Our bursary schemes help to encourage that. Some fantastic teachers are now coming into the profession, which will help us to further build the STEM pipeline.
We are trying to make sure that some of the very best graduates in STEM subjects go into teaching. Our bursary schemes help to encourage that. Some fantastic teachers are now coming into the profession, which will help us to further build the STEM pipeline.
In a free market, the shortage of science teachers to inspire young women would be addressed by a rising wage. It is worth a try.
Research from the Institution of Engineering and Technology shows that science, technology, engineering and maths-based toys are three times more likely to be targeted at boys than at girls. I should declare an interest as a chartered engineer in the IET. Will the Secretary of State declare her support for the Let Toys Be Toys campaign, which aims to give girls and boys, in the run-up to Christmas, a real choice about the kinds of toys they can enjoy and the careers they can have?
Research from the Institution of Engineering and Technology shows that science, technology, engineering and maths-based toys are three times more likely to be targeted at boys than at girls. I should declare an interest as a chartered engineer in the IET. Will the Secretary of State declare her support for the Let Toys Be Toys campaign, which aims to give girls and boys, in the run-up to Christmas, a real choice about the kinds of toys they can enjoy and the careers they can have?
The hon. Lady is right to highlight this. There are no boys’ careers and girls’ careers anymore—these careers should be open to all children. A person’s gender should not matter. As we have said, part of how we fix this challenge is by working in schools. I was very proud last month when one of my own schools, Ashcroft academy, won a STEM inspiration award for its Tuesday lunchtime STEM club. Such initiatives might seem small, but they have a profound effect on improving children’s interest in taking STEM forward.
The hon. Lady is right to highlight this. There are no boys’ careers and girls’ careers anymore—these careers should be open to all children. A person’s gender should not matter. As we have said, part of how we fix this challenge is by working in schools. I was very proud last month when one of my own schools, Ashcroft academy, won a STEM inspiration award for its Tuesday lunchtime STEM club. Such initiatives might seem small, but they have a profound effect on improving children’s interest in taking STEM forward.
The hon. Lady is right to highlight this. There are no boys’ careers and girls’ careers anymore—these careers should be open to all children. A person’s gender should not matter. As we have said, part of how we fix this challenge is by working in schools. I was very proud last month when one of my own schools, Ashcroft academy, won a STEM inspiration award for its Tuesday lunchtime STEM club. Such initiatives might seem small, but they have a profound effect on improving children’s interest in taking STEM forward.
Research from the Institution of Engineering and Technology shows that science, technology, engineering and maths-based toys are three times more likely to be targeted at boys than at girls. I should declare an interest as a chartered engineer in the IET. Will the Secretary of State declare her support for the Let Toys Be Toys campaign, which aims to give girls and boys, in the run-up to Christmas, a real choice about the kinds of toys they can enjoy and the careers they can have?
What steps she is taking to encourage more women to take up scientific professions.
What steps she is taking to encourage more women to take up scientific professions.
It is vital that we encourage talented women into scientific careers. Those working in science, technology, engineering and maths careers on average earn a pay premium of 19%. Ensuring that women work in STEM careers will also help to tackle the gender pay gap. Role models are absolutely crucial for young women, and some 40% of STEM ambassadors are women.
I would like to take this opportunity to put on record my thanks to Tim Peake, who did an amazing job of working with schools while he was on his space trip earlier this year. I have met many, many schoolchildren who have had their interest in STEM stimulated from the work he did while on his space trip.
The Government are looking at more than 50 sectors and at the cross-cutting regulatory issues to build a detailed understanding of how withdrawing from the European Union will impact on the UK, including in the important area of medical research and innovation. The recently formed UK EU Life Sciences Steering Group is engaging with a wide range of stakeholders to help us ensure a positive outcome for this sector and for UK science.
The Government are looking at more than 50 sectors and at the cross-cutting regulatory issues to build a detailed understanding of how withdrawing from the European Union will impact on the UK, including in the important area of medical research and innovation. The recently formed UK EU Life Sciences Steering Group is engaging with a wide range of stakeholders to help us ensure a positive outcome for this sector and for UK science.
To ask Her Majesty’s Government, in the light of the numbers of European Union scientists working on British research programmes, what assessment they have made of the impact of the United Kingdom’s exit from the European Union on medical research and innovation.
I am grateful to the noble Baroness for that Answer. Does she appreciate that what medical researchers in the UK really want to know is what is going to happen after Horizon 2020? Are the Government aware of the risk that there will be to the great progress now being made by UK researchers working with European teams, networks
and funding in, for example, the treatment of cancer and rare diseases? If those researchers are excluded from the next research framework, Framework Programme 9, that progress will come to a halt. In short, can she say what specific plans the Government have to ensure that we are not excluded from framework 9?
I am grateful to the noble Baroness for that Answer. Does she appreciate that what medical researchers in the UK really want to know is what is going to happen after Horizon 2020? Are the Government aware of the risk that there will be to the great progress now being made by UK researchers working with European teams, networks
and funding in, for example, the treatment of cancer and rare diseases? If those researchers are excluded from the next research framework, Framework Programme 9, that progress will come to a halt. In short, can she say what specific plans the Government have to ensure that we are not excluded from framework 9?
My Lords, it is too early to speculate on our future relationship with Horizon 2020 and its successor programme, No. 9—I am assured that it is going to be given a better name. Whatever happens in the future, we are committed to ensuring that the UK continues to be a world leader in international research and innovation and that collaboration with Europe and others continues. Separately, and as part of our industrial strategy, the Prime Minister has today announced a substantial real-terms increase in government investment in R&D worth £2 billion per year by 2020 as well as a new industrial strategy challenge fund which will also help medical innovation. This is good news.
My Lords, it is too early to speculate on our future relationship with Horizon 2020 and its successor programme, No. 9—I am assured that it is going to be given a better name. Whatever happens in the future, we are committed to ensuring that the UK continues to be a world leader in international research and innovation and that collaboration with Europe and others continues. Separately, and as part of our industrial strategy, the Prime Minister has today announced a substantial real-terms increase in government investment in R&D worth £2 billion per year by 2020 as well as a new industrial strategy challenge fund which will also help medical innovation. This is good news.
My Lords, it is too early to speculate on our future relationship with Horizon 2020 and its successor programme, No. 9—I am assured that it is going to be given a better name. Whatever happens in the future, we are committed to ensuring that the UK continues to be a world leader in international research and innovation and that collaboration with Europe and others continues. Separately, and as part of our industrial strategy, the Prime Minister has today announced a substantial real-terms increase in government investment in R&D worth £2 billion per year by 2020 as well as a new industrial strategy challenge fund which will also help medical innovation. This is good news.
I am grateful to the noble Baroness for that Answer. Does she appreciate that what medical researchers in the UK really want to know is what is going to happen after Horizon 2020? Are the Government aware of the risk that there will be to the great progress now being made by UK researchers working with European teams, networks
and funding in, for example, the treatment of cancer and rare diseases? If those researchers are excluded from the next research framework, Framework Programme 9, that progress will come to a halt. In short, can she say what specific plans the Government have to ensure that we are not excluded from framework 9?
My Lords, perhaps I may remind the House of my interest in this area. The Minister in the other place said in June that the life sciences industry was worth around £60 billion a year to the UK and supports some 220,000 jobs, We in this House know that the role of the industry in promoting better patient outcomes through clinical research is absolutely vital. Is the Minister able to give us some reassurance that regulation will be put on a more even footing in the future, and will the Government commit to signing up to the agreed 2014 clinical trials regulations when they come into effect in 2018?
My Lords, perhaps I may remind the House of my interest in this area. The Minister in the other place said in June that the life sciences industry was worth around £60 billion a year to the UK and supports some 220,000 jobs, We in this House know that the role of the industry in promoting better patient outcomes through clinical research is absolutely vital. Is the Minister able to give us some reassurance that regulation will be put on a more even footing in the future, and will the Government commit to signing up to the agreed 2014 clinical trials regulations when they come into effect in 2018?
I entirely agree with the noble Baroness about the importance of our unique life science industries. Regarding the clinical trials regulation, preparations are continuing to implement that regulation in 2018 because we remain in the EU while negotiations continue. Of course, a great repeal Bill will come before Parliament after the next Queen’s Speech. That will end the authority of EU law and return power to the UK, but we will transpose current EU law into domestic law while allowing for amendments to take account of the future negotiated UK-EU relationship in this and other areas.
I entirely agree with the noble Baroness about the importance of our unique life science industries. Regarding the clinical trials regulation, preparations are continuing to implement that regulation in 2018 because we remain in the EU while negotiations continue. Of course, a great repeal Bill will come before Parliament after the next Queen’s Speech. That will end the authority of EU law and return power to the UK, but we will transpose current EU law into domestic law while allowing for amendments to take account of the future negotiated UK-EU relationship in this and other areas.
I entirely agree with the noble Baroness about the importance of our unique life science industries. Regarding the clinical trials regulation, preparations are continuing to implement that regulation in 2018 because we remain in the EU while negotiations continue. Of course, a great repeal Bill will come before Parliament after the next Queen’s Speech. That will end the authority of EU law and return power to the UK, but we will transpose current EU law into domestic law while allowing for amendments to take account of the future negotiated UK-EU relationship in this and other areas.
My Lords, perhaps I may remind the House of my interest in this area. The Minister in the other place said in June that the life sciences industry was worth around £60 billion a year to the UK and supports some 220,000 jobs, We in this House know that the role of the industry in promoting better patient outcomes through clinical research is absolutely vital. Is the Minister able to give us some reassurance that regulation will be put on a more even footing in the future, and will the Government commit to signing up to the agreed 2014 clinical trials regulations when they come into effect in 2018?
My Lords, does the Minister accept that if we are to succeed in medical science research and innovation we need more home-grown science and maths graduates? That requires more science and maths teachers in our schools. Is she aware that teacher training targets are being missed, that vacancies are rising, that retention rates are falling, and that now more than a quarter of maths and science teachers have no relevant post A-level qualifications? What action are the Government taking?
My Lords, does the Minister accept that if we are to succeed in medical science research and innovation we need more home-grown science and maths graduates? That requires more science and maths teachers in our schools. Is she aware that teacher training targets are being missed, that vacancies are rising, that retention rates are falling, and that now more than a quarter of maths and science teachers have no relevant post A-level qualifications? What action are the Government taking?
The situation on STEM teaching is incredibly important. Indeed, thinking about our skills and how they relate to our industrial base, and our research and innovation will be a key strand of our industrial strategy, on which we will issue a consultation paper this side of Christmas.
The situation on STEM teaching is incredibly important. Indeed, thinking about our skills and how they relate to our industrial base, and our research and innovation will be a key strand of our industrial strategy, on which we will issue a consultation paper this side of Christmas.
The situation on STEM teaching is incredibly important. Indeed, thinking about our skills and how they relate to our industrial base, and our research and innovation will be a key strand of our industrial strategy, on which we will issue a consultation paper this side of Christmas.
My Lords, does the Minister accept that if we are to succeed in medical science research and innovation we need more home-grown science and maths graduates? That requires more science and maths teachers in our schools. Is she aware that teacher training targets are being missed, that vacancies are rising, that retention rates are falling, and that now more than a quarter of maths and science teachers have no relevant post A-level qualifications? What action are the Government taking?
My Lords, is it not inevitable that we will lose the European Medicines Agency in Canary Wharf, with its consequent expertise and jobs?
My Lords, is it not inevitable that we will lose the European Medicines Agency in Canary Wharf, with its consequent expertise and jobs?
All I can do is repeat that it is too early to speculate on detailed issues such as the future of the European Medicines Agency, but our approach remains to be fully open and supportive of scientists, researchers and our medical strength. This is particularly famous in the UK because of the National Health Service, which provides such a good base for our medical and pharmaceutical industries.
All I can do is repeat that it is too early to speculate on detailed issues such as the future of the European Medicines Agency, but our approach remains to be fully open and supportive of scientists, researchers and our medical strength. This is particularly famous in the UK because of the National Health Service, which provides such a good base for our medical and pharmaceutical industries.
All I can do is repeat that it is too early to speculate on detailed issues such as the future of the European Medicines Agency, but our approach remains to be fully open and supportive of scientists, researchers and our medical strength. This is particularly famous in the UK because of the National Health Service, which provides such a good base for our medical and pharmaceutical industries.
My Lords, is it not inevitable that we will lose the European Medicines Agency in Canary Wharf, with its consequent expertise and jobs?
Is my noble friend aware that one has only to go up to Cambridge and look at the number of start-up companies that are there, then open up the file on the new companies dealing with medical discovery going on the AIM market, to have some considerable reassurance that the industry is confident of the future, recognises that there will be some transitional challenges but, as before we joined the EU, will continue to be a leader in medical research?
Is my noble friend aware that one has only to go up to Cambridge and look at the number of start-up companies that are there, then open up the file on the new companies dealing with medical discovery going on the AIM market, to have some considerable reassurance that the industry is confident of the future, recognises that there will be some transitional challenges but, as before we joined the EU, will continue to be a leader in medical research?
I entirely agree with my noble friend. The fund for backing priority technologies, which we have announced today, will further support the UK’s potential to turn strengths in research into a global, industrial and commercial lead.
I entirely agree with my noble friend. The fund for backing priority technologies, which we have announced today, will further support the UK’s potential to turn strengths in research into a global, industrial and commercial lead.
I entirely agree with my noble friend. The fund for backing priority technologies, which we have announced today, will further support the UK’s potential to turn strengths in research into a global, industrial and commercial lead.
Is my noble friend aware that one has only to go up to Cambridge and look at the number of start-up companies that are there, then open up the file on the new companies dealing with medical discovery going on the AIM market, to have some considerable reassurance that the industry is confident of the future, recognises that there will be some transitional challenges but, as before we joined the EU, will continue to be a leader in medical research?
My Lords, I declare an interest as professor of surgery at University College London and business ambassador for healthcare and life sciences. The announcement of £2 billion a year of additional funding to support research and development is most welcome, but are Her Majesty’s Government able to confirm that that funding, in addition to driving an industrial strategy in this area, will be delivered through the activities of the research councils, secure excellence in terms of the purpose of research funding, and be used to ensure the ongoing participation of our great institutions in global collaborative networks, which are vital for the delivery of excellent science?
My Lords, I declare an interest as professor of surgery at University College London and business ambassador for healthcare and life sciences. The announcement of £2 billion a year of additional funding to support research and development is most welcome, but are Her Majesty’s Government able to confirm that that funding, in addition to driving an industrial strategy in this area, will be delivered through the activities of the research councils, secure excellence in terms of the purpose of research funding, and be used to ensure the ongoing participation of our great institutions in global collaborative networks, which are vital for the delivery of excellent science?
I entirely agree with the noble Lord on the excellence of our research and development base, and on the great work being done by the research councils. I look forward to debating the way forward when the Bill on education and research reaches this House in the coming weeks. New funding has been made available today. This vision and direction of travel is excellent news for our science and research base in every part of the country.